BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32605438)

  • 1. Subcortical Signatures of Hemizygosity and Psychosis in 22q11.2 Deletion Syndrome: Finding Common Ground in Rare Genetic Variation.
    Eisenberg DP; Gregory MD; Berman KF
    Am J Psychiatry; 2020 Jul; 177(7):564-566. PubMed ID: 32605438
    [No Abstract]   [Full Text] [Related]  

  • 2. Completing the puzzle: The search for pieces in the understanding of psychosis risk in 22q11.2 deletion syndrome.
    Hooper SR; Shashi V
    Schizophr Res; 2017 Oct; 188():33-34. PubMed ID: 28768602
    [No Abstract]   [Full Text] [Related]  

  • 3. 22q11.2 Deletion Syndrome: Characterization of Psychosis Spectrum and Future Directions.
    Radoeva PD
    Biol Psychiatry; 2017 Jul; 82(1):e5-e7. PubMed ID: 28619254
    [No Abstract]   [Full Text] [Related]  

  • 4. Urinary Anomalies in 22q11.2 Deletion (DiGeorge syndrome): From Copy Number Variations to Single-Gene Determinants of Phenotype.
    Hall G; Routh JC; Gbadegesin RA
    Am J Kidney Dis; 2017 Jul; 70(1):8-10. PubMed ID: 28456345
    [No Abstract]   [Full Text] [Related]  

  • 5. Dynamic Functional Connectivity: A New Perspective on 22q11.2 Deletion Syndrome and Psychosis.
    Schmitt JE
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Oct; 4(10):852-853. PubMed ID: 31590721
    [No Abstract]   [Full Text] [Related]  

  • 6. Does 22q11.2 deletion syndrome contribute to the genetic aetiology of Parkinson's disease?
    Fung W; Peall KJ
    J Neurol; 2018 Oct; 265(10):2463-2465. PubMed ID: 30238269
    [No Abstract]   [Full Text] [Related]  

  • 7. Non-pharmacological treatment of psychiatric disorders in individuals with 22q11.2 deletion syndrome; a systematic review.
    Buijs PCM; Bassett AS; Boot E
    Am J Med Genet A; 2018 Aug; 176(8):1742-1747. PubMed ID: 29363845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Education and employment trajectories from childhood to adulthood in individuals with 22q11.2 deletion syndrome.
    Mosheva M; Pouillard V; Fishman Y; Dubourg L; Sofrin-Frumer D; Serur Y; Weizman A; Eliez S; Gothelf D; Schneider M
    Eur Child Adolesc Psychiatry; 2019 Jan; 28(1):31-42. PubMed ID: 29934817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent developments in understanding the relationship between 22q11.2 deletion syndrome and psychosis.
    O'Rourke L; Murphy KC
    Curr Opin Psychiatry; 2019 Mar; 32(2):67-72. PubMed ID: 30394904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Better Understanding of Brain Involvement in 22q11.2 Deletion Syndrome.
    Del Giudice E
    Pediatr Neurol; 2018 Jan; 78():e5. PubMed ID: 29167055
    [No Abstract]   [Full Text] [Related]  

  • 11. Biological effects of COMT haplotypes and psychosis risk in 22q11.2 deletion syndrome.
    Gothelf D; Law AJ; Frisch A; Chen J; Zarchi O; Michaelovsky E; Ren-Patterson R; Lipska BK; Carmel M; Kolachana B; Weizman A; Weinberger DR
    Biol Psychiatry; 2014 Mar; 75(5):406-13. PubMed ID: 23992923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to Correspondence on "A Better Understanding of Brain Involvement in 22q11.2 Deletion Syndrome".
    Mudigoudar B; Wheless JW
    Pediatr Neurol; 2018 Jan; 78():e7. PubMed ID: 29174003
    [No Abstract]   [Full Text] [Related]  

  • 13. Associations between neurodevelopmental genes, neuroanatomy, and ultra high risk symptoms of psychosis in 22q11.2 deletion syndrome.
    Thompson CA; Karelis J; Middleton FA; Gentile K; Coman IL; Radoeva PD; Mehta R; Fremont WP; Antshel KM; Faraone SV; Kates WR
    Am J Med Genet B Neuropsychiatr Genet; 2017 Apr; 174(3):295-314. PubMed ID: 28139055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathways to understanding psychosis through rare - 22q11.2DS - and common variants.
    Gur RE; Roalf DR; Alexander-Bloch A; McDonald-McGinn DM; Gur RC
    Curr Opin Genet Dev; 2021 Jun; 68():35-40. PubMed ID: 33571729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical response inhibition and error processing in 22q11.2 Deletion Syndrome and schizophrenia: Towards neuromarkers of disease progression and risk.
    Francisco AA; Horsthuis DJ; Popiel M; Foxe JJ; Molholm S
    Neuroimage Clin; 2020; 27():102351. PubMed ID: 32731196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome.
    Bassett AS; Marshall CR; Lionel AC; Chow EW; Scherer SW
    Hum Mol Genet; 2008 Dec; 17(24):4045-53. PubMed ID: 18806272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosis Beyond the 22q11.2 Deletion: Do Additional Genetic Factors Play a Role?
    Goes FS; Sawa A
    Am J Psychiatry; 2017 Nov; 174(11):1027-1029. PubMed ID: 29088933
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diagnosis of 22q11.2 deletion syndrome in the context of newly developed psychosis].
    Kaltenboeck A; Friedrich F; Hinterbuchinger B; Litvan Z; Mossaheb N
    Neuropsychiatr; 2016 Dec; 30(4):223-226. PubMed ID: 27822729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome.
    Gothelf D; Feinstein C; Thompson T; Gu E; Penniman L; Van Stone E; Kwon H; Eliez S; Reiss AL
    Am J Psychiatry; 2007 Apr; 164(4):663-9. PubMed ID: 17403981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rare mosaic 22q11.2 microdeletion identified in a Chinese family with recurrent fetal conotruncal defects.
    Chen W; Li X; Sun L; Sheng W; Huang G
    Mol Genet Genomic Med; 2019 Aug; 7(8):e847. PubMed ID: 31297990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.